Skip to main content
. Author manuscript; available in PMC: 2014 Dec 16.
Published in final edited form as: Nat Commun. 2014 Nov 21;5:5383. doi: 10.1038/ncomms6383

Figure 8. NEAT1 overexpression is associated with aggressive prostate cancer.

Figure 8

(a-b) Kaplan Meier curves showing (a) Biochemical recurrence (BCR) free survival and (b) metastatic recurrence (MET) free survival for NEAT1 low and high expression groups of samples from the Mayo case-cohort dataset 35(n = 216). The cut points to define high and low NEAT1 expression were selected using patients from the Mayo nested case-control dataset (n = 378) 58 by maximizing the product of the sensitivity and specificity for each endpoint. The number of patients at risk for each group is shown beneath the plot.